Samer Al Hadidi, M.D., M.S., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in hematology and oncology, with an emphasis on plasma cell disorders, including multiple myeloma and light chain amyloidosis, and cellular therapies, including CAR T-cell therapy and hematopoietic stem cell transplantation.

Dr. Al Hadidi earned his medical degree at the University of Jordan School of Medicine. He completed a residency in internal medicine at Hurley Medical Center/Michigan State University. He received advanced training through a hematology and oncology fellowship at Baylor College of Medicine in Houston. He also holds a master’s degree in clinical research and statistical analysis from the University of Michigan in Ann Arbor.

Dr. Al Hadidi is the Clinical Director of the Amyloidosis Program at UT Southwestern. He also serves as Leader of the Fellows’ Plasma Cell Disorders Clinic. He is nationally recognized as an expert in treating multiple myeloma and utilizing cellular therapies for plasma cell disorders.Dr. Al Hadidi serves on the Hematology Specialty Board of the American Board of Internal Medicine, helping to oversee certification standards, specialty assessment, and governance policies for hematology.

Dr. Al Hadidi has delivered national and international presentations and published more than 140 peer-reviewed academic articles related to his areas of expertise.